These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19500072)

  • 1. Gender differences in aminoglycoside induced nephrotoxicity: a prospective, hospital-based study.
    Sweileh WM
    Curr Clin Pharmacol; 2009 Sep; 4(3):229-32. PubMed ID: 19500072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
    Sweileh WM
    Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gentamicin and amikacin nephrotoxicity: comparative study in patients with initially normal renal function].
    Ballesteros J; Northland R; Wolff M
    Rev Med Chil; 1989 Jan; 117(1):10-7. PubMed ID: 2641618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity induced by gentamicin and amikacin.
    Smith CR; Maxwell RR; Edwards CQ; Rogers JF; Lietman PS
    Johns Hopkins Med J; 1978 Mar; 142(3):85-90. PubMed ID: 342789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity.
    Smith CR; Lipsky JJ; Lietman PS
    Antimicrob Agents Chemother; 1979 Jun; 15(6):780-2. PubMed ID: 475363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside-induced nephrotoxicity.
    Wargo KA; Edwards JD
    J Pharm Pract; 2014 Dec; 27(6):573-7. PubMed ID: 25199523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides.
    Raveh D; Kopyt M; Hite Y; Rudensky B; Sonnenblick M; Yinnon AM
    QJM; 2002 May; 95(5):291-7. PubMed ID: 11978900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
    Arroyo JC; Milligan WL; Davis J; Mitchell D
    South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin.
    Gatell JM; SanMiguel JG; Zamora L; Araujo V; Castells C; Moreno A; Jimenez de Anta MT; Marin JL; Elena M; Ballesta A
    Nephron; 1985; 41(4):337-43. PubMed ID: 3906418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proximal tubule damage in patients treated with gentamicin or amikacin.
    Wiland P; Szechciński J
    Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination.
    Goetz MB; Sayers J
    J Antimicrob Chemother; 1993 Aug; 32(2):325-34. PubMed ID: 8226435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between the nephrotoxic profile of gentamicin and gentamicin nanoparticles in mice.
    Jamshidzadeh A; Heidari R; Mohammadi-Samani S; Azarpira N; Najbi A; Jahani P; Abdoli N
    J Biochem Mol Toxicol; 2015 Feb; 29(2):57-62. PubMed ID: 25293820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR; Lucarotti RL; Shapiro HS
    Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside prescription, therapeutic monitoring and nephrotoxicity at a university hospital in Saudi Arabia.
    Eltahawy AT; Bahnassy AA
    J Chemother; 1996 Aug; 8(4):278-83. PubMed ID: 8873833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical assessment of a published model to predict aminoglycoside-induced nephrotoxicity.
    Garrison MW; Rotschafer JC
    Ther Drug Monit; 1989; 11(2):171-5. PubMed ID: 2718222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
    de Jager P; van Altena R
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):622-7. PubMed ID: 12102302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside-related nephrotoxicity in the premature newborn.
    Rajchgot P; Prober CG; Soldin S; Perlman M; Good F; Harding E; Klein J; MacLeod S
    Clin Pharmacol Ther; 1984 Mar; 35(3):394-401. PubMed ID: 6365403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of grape seed proanthocyanidin extract in preventing amikacin-induced nephropathy.
    Ulusoy S; Ozkan G; Ersoz S; Orem A; Alkanat M; Yucesan FB; Kaynar K; Al S
    Ren Fail; 2012; 34(2):227-34. PubMed ID: 22263836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.